Deepseq was founded by Bernhard Suter.

Who are Deepseq's investors?

Deepseq's investors include Illumina Ventures, ZAKA VC.

Deepseq

2 known investors

Find your way into Deepseq

57 people in our graph share verified history with the Deepseq team — schools, employers, funds. One of them is your warm intro.

Elisa Kiebackunlockedknows Bernhard Suter · together at Max Delbrück Centrum Berlin (overlapped)

×2knows the team · via University of Bern

×2knows the team · via ETH Zürich

×3knows the team · via BioTools Innovator

×4knows the team · via Max Delbrück Centrum Berlin

DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. It aims to accelerate the development of better biologic therapeutics for patients.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Bernhard Suter FounderBernhard Suter is a scientist and founder with 15+ years of experience in R&D and technology development in biotech startups and established companies. He spent over 10 years at Next Interactions working on protein sequencing and statistical methods, and currently leads platform and wet lab development at DeepSeq, which uses AI to design biologic drugs.

Investors · 2

Illumina Ventureslisted by Illumina VenturesFoster City

How we know: Illumina Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

ZAKA VClisted by ZAKA VCSan Francisco

Competitors · 3

by search overlap

DeepSee5 shared keywordsDeepSee.ai develops technology aimed at supporting knowledge workers and improving business operations. The page provides limited detail beyond a hiring notice.

Tempus4 shared keywordsTempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.

Deepchecks4 shared keywordsDeepchecks offers an enterprise LLM evaluation platform that unifies testing, observability, and monitoring for AI systems in production. It lets AI teams compare prompt/model/agent versions, set up auto-scoring pipelines, create LLM judges and datasets, and integrate LLM app testing into CI/CD.

Companies competing with Deepseq for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Deepseq do?: DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. It aims to accelerate the development of better biologic therapeutics for patients.
Who founded Deepseq?: Deepseq was founded by Bernhard Suter.
Who are Deepseq's investors?: Deepseq's investors include Illumina Ventures, ZAKA VC.